Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05167409 |
| Title | A Study of ALX148 With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Criterium, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Arizona Cancer Center | Recruiting | Tucson | Arizona | 85724 | United States | Details |
| University of Colorado Cancer Center | Recruiting | Aurora | Colorado | 80045 | United States | Details |
| Rutgers Cancer insititute | Recruiting | New Brunswick | New Jersey | 08903 | United States | Details |
| Perlmutter Cancer Center | Not yet recruiting | New York | New York | 10016 | United States | Details |
| Inova Schar Cancer Institute | Not yet recruiting | Fairfax | Virginia | 22031 | United States | Details |